leisure time -WSS

leisure time

author：focus 2025-08-23 08:52:59 - browse：6

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Even great ERs can’t make up for American health disparities

focus

WSS

A new initiative will help leaders fight the next pandemic

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Elevance PBM president out as customers face prescription chaos

Biden administration opens offers in Medicare drug price negotiations

SAMSHA loosens regulations on methadone treatment centers

Novo Nordisk to expand supply of Wegovy for U.S. patients

hotspot

leisure time

focus

Hepatitis C has a cure — but many Americans still lack access to it

Covid misinformation case heads to Supreme Court

Wildfire smoke exposes gaps in outdoor worker protections

Senators tussle over abortion against the backdrop of a presidential campaign

Medicare details structure of new drug price negotiation program

Woodcock on FDA’s accelerated approval and her next chapter

New air purifier tech could be key to improving indoor air quality

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Trump demands the U.S. pay no more for drugs than other countries … again

Vertex non

hotspot

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Even great ERs can’t make up for American health disparities

Medicare Advantage's lean provider networks lead CMS complaints

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Vertex non

Congress needs to close a vaccine

focus

focus

hotspot

entertainment